Related references
Note: Only part of the references are listed.A Th17-and Th2-skewed Cytokine Profile in Cystic Fibrosis Lungs Represents a Potential Risk Factor for Pseudomonas aeruginosa Infection
Kerstin Tiringer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Update in Cystic Fibrosis 2012
Christopher H. Goss et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF
A. Krause et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Collaboration Between Macrophages and Vaccine-Induced CD4+ T Cells Confers Protection Against Lethal Pseudomonas aeruginosa Pneumonia During Neutropenia
Akinobu Kamei et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa
Anurag Sharma et al.
PLOS ONE (2013)
Th17-stimulating Protein Vaccines Confer Protection against Pseudomonas aeruginosa Pneumonia
Weihui Wu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: A randomized, double-blind, placebo-controlled trial
Bruno Francois et al.
CRITICAL CARE MEDICINE (2012)
40 years on: have we finally got a vaccine for Pseudomonas aeruginosa?
Stefan Worgall
FUTURE MICROBIOLOGY (2012)
Topical Neutralization of Interleukin-17 during Experimental Pseudomonas aeruginosa Corneal Infection Promotes Bacterial Clearance and Reduces Pathology
Tanweer S. Zaidi et al.
INFECTION AND IMMUNITY (2012)
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening
Antonio DiGiandomenico et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
Alejandro A. Pezzulo et al.
NATURE (2012)
Cystic fibrosis: a mucosal immunodeficiency syndrome
Taylor Sitarik Cohen et al.
NATURE MEDICINE (2012)
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Anders Folkesson et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota
Amanda F. Goddard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures
J. C. Madan et al.
MBIO (2012)
The Th17 Pathway in Cystic Fibrosis Lung Disease
Hui-Leng Tan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Recent developments for Pseudomonas vaccines
Anurag Sharma et al.
HUMAN VACCINES (2011)
Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity
Kong Chen et al.
IMMUNITY (2011)
Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity against Pseudomonas aeruginosa Acute Lung Infection
Akinobu Kamei et al.
INFECTION AND IMMUNITY (2011)
Efficacy of a Conjugate Vaccine Containing Polymannuronic Acid and Flagellin against Experimental Pseudomonas aeruginosa Lung Infection in Mice
Victoria L. Campodonico et al.
INFECTION AND IMMUNITY (2011)
Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection
T. Secher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
Qin Lu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
Christopher D. Sibley et al.
PLOS ONE (2011)
Multi-functional characteristics of the Pseudomonas aeruginosa type III needle-tip protein, PcrV; comparison to orthologs in other Gram-negative bacteria
Hiromi Sato et al.
FRONTIERS IN MICROBIOLOGY (2011)
Western Trauma Association/Critical Decisions in Trauma: Operative Management of Adult Blunt Hepatic Trauma
Rosemary A. Kozar et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2011)
Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11
Michael P. Horn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Diagnosis and Management of Infectious Complications in Critically Ill Patients with Cancer
Raghukumar Thirumala et al.
CRITICAL CARE CLINICS (2010)
Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection
M. D. Parkins et al.
INFECTION (2010)
(1,3)-β-Glucans Activate Both Dectin-1 and NLRP3 Inflammasome in Human Macrophages
Paivi Kankkunen et al.
JOURNAL OF IMMUNOLOGY (2010)
Utility of In Vivo Transcription Profiling for Identifying Pseudomonas aeruginosa Genes Needed for Gastrointestinal Colonization and Dissemination
Andrew Y. Koh et al.
PLOS ONE (2010)
OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa
Bin Ding et al.
VACCINE (2010)
Role of Neutrophils, MyD88-Mediated Neutrophil Recruitment, and Complement in Antibody-Mediated Defense against Pseudomonas aeruginosa Keratitis
Tanweer S. Zaidi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Pharmacokinetics and Safety Profile of the Human Anti-Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers
Hedvika Lazar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
Mark Baer et al.
INFECTION AND IMMUNITY (2009)
Genome-Wide Study of Pseudomonas aeruginosa Outer Membrane Protein Immunogenicity Using Self-Assembling Protein Microarrays
Wagner R. Montor et al.
INFECTION AND IMMUNITY (2009)
A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
INFECTION AND IMMUNITY (2009)
Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia
Andrew Y. Koh et al.
INFECTION AND IMMUNITY (2009)
Intranasal Immunization Promotes Th17 Immune Responses
Beata M. Zygmunt et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production
Matthew S. Byrd et al.
MOLECULAR MICROBIOLOGY (2009)
Pseudomonas aeruginosa Population Structure Revisited
Jean-Paul Pirnay et al.
PLOS ONE (2009)
Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
VACCINE (2009)
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa
Gregory P. Priebe et al.
JOURNAL OF IMMUNOLOGY (2008)
Induction and effector functions of TH17 cells
Estelle Bettelli et al.
NATURE (2008)
Good effect of IgY against infections in cystic Pseudomonas aeruginosa fibrosis patients
Elin Nilsson et al.
PEDIATRIC PULMONOLOGY (2008)
Vaccines and immunotherapy against Pseudomonas aeruginosa
Gerd Doering et al.
VACCINE (2008)
Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis
Tanweer Zaidi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice
Jennifer M. Scarff et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
Gerd Doering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17
Salome LeibundGut-Landmann et al.
NATURE IMMUNOLOGY (2007)
Trauma-related infections in battlefield casualties from Iraq
Kyle Petersen et al.
ANNALS OF SURGERY (2007)
Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections
Antonio DiGiandomenico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
In harm's way: Infections in deployed American military forces
Naomi E. Aronson et al.
CLINICAL INFECTIOUS DISEASES (2006)
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Yutaka Komiyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Eric E. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection
TS Zaidi et al.
INFECTION AND IMMUNITY (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
N Safdar et al.
CRITICAL CARE MEDICINE (2005)
Overview of nosocomial infections caused by gram-negative bacilli
R Gaynes et al.
CLINICAL INFECTIOUS DISEASES (2005)
Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model
A Bragonzi et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Recognition of host immune activation by Pseudomonas aeruginosa
LC Wu et al.
SCIENCE (2005)
Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-a and granulocyte colony-stimulating factor in bronchial epithelium: Implications for airway inflammation in cystic fibrosis
F McAllister et al.
JOURNAL OF IMMUNOLOGY (2005)
Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes
ZZ Lai et al.
VACCINE (2005)
Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa
EE Smith et al.
JOURNAL OF BACTERIOLOGY (2005)
Oral vaccination of BALB/c mice with Salmonella enterica serovar typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model
A DiGiandomenico et al.
INFECTION AND IMMUNITY (2004)
Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains
GB Pier et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection
AB Lang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen
GB Pier
CARBOHYDRATE RESEARCH (2003)
Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis:: A phase I feasibility study
H Kollberg et al.
PEDIATRIC PULMONOLOGY (2003)
Cutting edge:: Roles of toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection
KI Happel et al.
JOURNAL OF IMMUNOLOGY (2003)
O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa
K Faure et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant
GP Priebe et al.
INFECTION AND IMMUNITY (2003)
Interleukin-17 - An emerging role in lung inflammation
JK Kolls et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV
DW Frank et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
PEGylated antibodies and antibody fragments for improved therapy: a review
AP Chapman
ADVANCED DRUG DELIVERY REVIEWS (2002)
Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine
GP Priebe et al.
INFECTION AND IMMUNITY (2002)
Therapeutic administration of anti-PcrV F(ab′)2 in sepsis associated with Pseudomonas aeruginosa
N Shime et al.
JOURNAL OF IMMUNOLOGY (2001)
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
H Feltman et al.
MICROBIOLOGY-SGM (2001)
Interleukin-17 and lung host defense against Klebsiella pneumoniae infection
P Ye et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense
P Ye et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P-aeruginosa-pulsed dendritic cells
S Worgall et al.
INFECTION AND IMMUNITY (2001)
Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis
S Hemachandra et al.
INFECTION AND IMMUNITY (2001)
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
JL Burns et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Peroral immunotheraphy with yolk antibodies for the prevention and treatment of enteric infections
D Carlander et al.
IMMUNOLOGIC RESEARCH (2000)
Share Paper
